Format

Send to

Choose Destination
J Proteome Res. 2019 Mar 1;18(3):1380-1391. doi: 10.1021/acs.jproteome.9b00004. Epub 2019 Feb 20.

Proteomic Atlas of the Human Brain in Alzheimer's Disease.

Author information

1
Morgridge Institute for Research , Madison , Wisconsin 53706 , United States.

Abstract

The brain represents one of the most divergent and critical organs in the human body. Yet, it can be afflicted by a variety of neurodegenerative diseases specifically linked to aging, about which we lack a full biomolecular understanding of onset and progression, such as Alzheimer's disease (AD). Here we provide a proteomic resource comprising nine anatomically distinct sections from three aged individuals, across a spectrum of disease progression, categorized by quantity of neurofibrillary tangles. Using state-of-the-art mass spectrometry, we identify a core brain proteome that exhibits only small variance in expression, accompanied by a group of proteins that are highly differentially expressed in individual sections and broader regions. AD affected tissue exhibited slightly elevated levels of tau protein with similar relative expression to factors associated with the AD pathology. Substantial differences were identified between previous proteomic studies of mature adult brains and our aged cohort. Our findings suggest considerable value in examining specifically the brain proteome of aged human populations from a multiregional perspective. This resource can serve as a guide, as well as a point of reference for how specific regions of the brain are affected by aging and neurodegeneration.

KEYWORDS:

Alzheimer’s disease; aged brain; brain tissue; cortical samples; human proteomics; limbic samples; mass spectrometry; multiregional; neurodegeneration; quantitative proteomics

PMID:
30735395
PMCID:
PMC6480317
[Available on 2020-03-01]
DOI:
10.1021/acs.jproteome.9b00004

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center